Treatment options for intrinsic sphincter deficiency

Area of Science:

• Urology
• Female Pelvic Medicine

Background:

• Type III stress urinary incontinence (SUI) is commonly linked to intrinsic sphincter deficiency (ISD).
• Current clinical parameters for ISD, such as Valsalva leak-point pressure (<60 cmH2O) and maximal urethral closure pressure (<20 cmH2O), lack consensus.
• This ambiguity complicates the interpretation of treatment success for ISD.

Purpose of the Study:

• To review current understanding and treatment options for SUI caused by ISD.
• To highlight the challenges in diagnosing and managing ISD due to a lack of standardized criteria.
• To emphasize the importance of assessing urethral function for tailored treatment selection.

Main Methods:

• Review of surgical and nonsurgical treatment studies for ISD over the past 20 years.
• Discussion of diagnostic parameters including leak-point pressure and urethral closure pressure.
• Exploration of treatments such as suburethral slings, artificial urinary sphincter, and bulking agents.

Main Results:

• A variety of surgical (retropubic suspension, slings, artificial urinary sphincter) and nonsurgical (bulking agents) treatments have been evaluated for ISD.
• No standardized diagnostic criteria or treatment protocols for ISD currently exist.
• Urethral function assessment is crucial for determining optimal patient management.

Conclusions:

• Standardized diagnostic criteria for ISD are needed to improve treatment outcome interpretation.
• Personalized treatment selection for SUI secondary to ISD should be guided by objective urethral function assessments.
• Further research may lead to standardized diagnostic and therapeutic approaches for intrinsic sphincter deficiency.